🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of this study is to test the hypothesis that a SSRI p...
Status
Completed
Location
University Hospital Outpatient Center, Psychiatry
Start Date
2008-02
Trial ID
NCT00619892
Treatments Being Tested
This placebo-controlled trial will test the effectiveness of Seroquel XR™ f...
Status
Completed
Location
VA Puget Sound Health Care System
Start Date
2008-02
Trial ID
NCT00631748
Treatments Being Tested
To add to our understanding of the relationship between blushing, symptom s...
Status
Completed
Location
START Clinic for the Mood and Anxiety Disorders
Start Date
2008-10
Trial ID
NCT00773162
Treatments Being Tested
In this study, quetiapine XR or placebo will be administered orally for 6 w...
Status
Completed
Location
Multiple Locations
Start Date
2011-12-14
Trial ID
NCT01725282
Treatments Being Tested
The purpose of this study is to assess the efficacy of seltorexant compared...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2020-09-15
Trial ID
NCT04513912
Treatments Being Tested
The primary purpose of this study is to evaluate whether treatment with (SE...
Status
Completed
Location
Research Site
Start Date
2006-09
Trial ID
NCT00389064
Treatments Being Tested
The purpose of this study is to find out whether an investigational drug ca...
Status
Completed
Location
Psychoneuroendocrine Research Program
Start Date
2007-03
Trial ID
NCT00457197
Treatments Being Tested
Lurasidone HCl is a compound being developed for the treatment of schizophr...
Status
Completed
Location
K&S Professional Research Services, LLC
Start Date
2008-10
Trial ID
NCT00790192
Treatments Being Tested
The purpose of this study is to assess the efficacy of flexibly dosed JNJ-4...
Status
Completed
Location
NoesisPharma Research
Start Date
2017-12-12
Trial ID
NCT03321526
This will be a phase IV 20 -32 day prospective, double blind, double-dummy,...
Status
Completed
Location
Research Site
Start Date
2010-11
Trial ID
NCT01213836